The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease

The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease

Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are the analysis of cerebral spinal fluid (CSF) to detect levels of Aβ42 and phosphorylated-tau, amyloid and FDG-PET, and MRI volumetry. Some of these procedures are still invasive for patients or expensive...

Full description

Bibliographic Details
Main Authors: Fernando Maestú, Pablo Cuesta, Omar Hasan, Alberto Fernandéz, Michael Funke, Paul E. Schulz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Human Neuroscience
Subjects:
functional connectivity
mild cognitive impairment
EEG
MEG
healthy aging
Alzheimer's disease
Online Access:https://www.frontiersin.org/article/10.3389/fnhum.2019.00017/full

Internet

https://www.frontiersin.org/article/10.3389/fnhum.2019.00017/full

Similar Items